Long-term prostacyclin reduces pulmonary vascular resistance in severe primary pulmonary hypertension.
Barst
R J
RJ
Columbia-Presbyterian Medical Center, Babies Hospital, Division of Pediatric Cardiology, New York, New York 10032, USA.
D000959:Antihypertensive Agents / Q000008:administration & dosage*; D011464:Epoprostenol / Q000008:administration & dosage*; D019317:Evidence-Based Medicine; D006801:Humans; D006976:Hypertension, Pulmonary / Q000188:drug therapy*; D011446:Prospective Studies; D013997:Time Factors; D014655:Vascular Resistance / Q000187:drug effects*; D014665:Vasodilator Agents / Q000008:administration & dosage
D000959:Antihypertensive Agents; D014665:Vasodilator Agents; D011464:Epoprostenol